IMIPRAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Imipramine Hydrochloride, and what generic alternatives are available?
Imipramine Hydrochloride is a drug marketed by Novartis, Chartwell, Leading, Lederle, Oxford Pharms, Par Pharm, Roxane, Sandoz, Specgx Llc, Strides Pharma, Sun Pharm Industries, Teva, Usl Pharma, Vangard, Watson Labs, and West Ward. and is included in thirty-six NDAs.
The generic ingredient in IMIPRAMINE HYDROCHLORIDE is imipramine hydrochloride. There are thirty-four drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the imipramine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Imipramine Hydrochloride
A generic version of IMIPRAMINE HYDROCHLORIDE was approved as imipramine hydrochloride by STRIDES PHARMA on October 21st, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IMIPRAMINE HYDROCHLORIDE?
- What are the global sales for IMIPRAMINE HYDROCHLORIDE?
- What is Average Wholesale Price for IMIPRAMINE HYDROCHLORIDE?
Summary for IMIPRAMINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 36 |
| Finished Product Suppliers / Packagers: | 12 |
| Raw Ingredient (Bulk) Api Vendors: | 111 |
| Clinical Trials: | 52 |
| Patent Applications: | 1,056 |
| DailyMed Link: | IMIPRAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for IMIPRAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wright State University | Phase 1 |
| Benha University | N/A |
| Wright State Physicians | Phase 1 |
Pharmacology for IMIPRAMINE HYDROCHLORIDE
| Drug Class | Tricyclic Antidepressant |
Anatomical Therapeutic Chemical (ATC) Classes for IMIPRAMINE HYDROCHLORIDE
US Patents and Regulatory Information for IMIPRAMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 085875-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Industries | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 081050-001 | Jun 5, 1990 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 085877-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 088262-001 | Oct 21, 1983 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 083729-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 088276-001 | Oct 21, 1983 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novartis | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | CONCENTRATE;ORAL | 086765-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
